ES2056086T3 - Procedimiento para la determinacion de fibrina soluble. - Google Patents

Procedimiento para la determinacion de fibrina soluble.

Info

Publication number
ES2056086T3
ES2056086T3 ES88114180T ES88114180T ES2056086T3 ES 2056086 T3 ES2056086 T3 ES 2056086T3 ES 88114180 T ES88114180 T ES 88114180T ES 88114180 T ES88114180 T ES 88114180T ES 2056086 T3 ES2056086 T3 ES 2056086T3
Authority
ES
Spain
Prior art keywords
determination
procedure
soluble fibrin
fibrin
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88114180T
Other languages
English (en)
Inventor
Udo Dr Becker
Konrad Braun
Norbert Prof Dr Heimburger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2056086T3 publication Critical patent/ES2056086T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO PARA DETERMINACION DE FIBRINA SOLUBLE EN UN LIQUIDO CORPORAL DE UNA ESPECIE, CON LO QUE SE UTILIZA PARA FIBRINA UN ASOCIADO BIOAFINADO MARCADO Y FORMADO EN UNA FASE SOLIDA
ES88114180T 1987-09-08 1988-08-31 Procedimiento para la determinacion de fibrina soluble. Expired - Lifetime ES2056086T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873730059 DE3730059A1 (de) 1987-09-08 1987-09-08 Verfahren zur bestimmung von "loeslichem" fibrin

Publications (1)

Publication Number Publication Date
ES2056086T3 true ES2056086T3 (es) 1994-10-01

Family

ID=6335495

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88114180T Expired - Lifetime ES2056086T3 (es) 1987-09-08 1988-08-31 Procedimiento para la determinacion de fibrina soluble.

Country Status (8)

Country Link
US (1) US6048684A (es)
EP (1) EP0306813B1 (es)
JP (1) JP2714562B2 (es)
AT (1) ATE106571T1 (es)
AU (1) AU613083B2 (es)
CA (1) CA1338774C (es)
DE (2) DE3730059A1 (es)
ES (1) ES2056086T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4134833A1 (de) * 1991-09-25 1993-04-01 Boehringer Mannheim Gmbh Verfahren zur bestimmung von fibrin
DE4420742A1 (de) * 1993-10-20 1995-04-27 Boehringer Mannheim Gmbh Synthetischer Standard für Immunoassays
FR2813395B1 (fr) 2000-08-28 2003-01-24 Stago Diagnostica Methode de dosage in vitro de la fibrine soluble par generation de produits de degradation specifiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4642285A (en) * 1975-09-29 1987-02-10 Diamedix Corporation Sandwich EIA for antigen
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
DE3400434A1 (de) * 1984-01-09 1985-09-26 Behringwerke Ag, 3550 Marburg Bestimmung von fibrin mit fibrin-spezifischen antikoerpern
US4914040A (en) * 1988-03-03 1990-04-03 Boehringer Mannheim Gmbh Reagent and method for determination of a polyvalent substance using an immunoaggregate

Also Published As

Publication number Publication date
ATE106571T1 (de) 1994-06-15
EP0306813B1 (de) 1994-06-01
AU2193488A (en) 1989-03-09
JP2714562B2 (ja) 1998-02-16
AU613083B2 (en) 1991-07-25
CA1338774C (en) 1996-12-10
EP0306813A3 (de) 1991-01-09
EP0306813A2 (de) 1989-03-15
US6048684A (en) 2000-04-11
DE3730059A1 (de) 1989-03-30
JPS6491060A (en) 1989-04-10
DE3889818D1 (de) 1994-07-07

Similar Documents

Publication Publication Date Title
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
IT1209634B (it) Trivellazione. procedimento di diagrafia acustica istantanea in un pozzo di
GB2207351B (en) Neutral endopeptidase inhibitors as agents for diuresis, natriuresis and thus lowering of blood pressure
ATE78098T1 (de) Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.
YU47648B (sh) Sredstvo za suspendovanje, konzerviranje i skladištenje ćelija, u prvom redu eritrocita i njegova primena
NO302883B1 (no) N-(alkanoylamino-2-hydroksypropyl)-sulfonamider som er nyttige som retrovirale proteaseinhibitorer, samt preparater inneholdene forbindelsene
DE3750849T2 (de) Feste kalziumphosphat-materialien.
DE3789371T2 (de) Aryloxy- und Arylacyloxymethyl-Ketone als Thiolprotease-Hemmungsstoffe.
DE3785615T2 (de) Hemmungsstoffe der serin-protease.
DE3853386T2 (de) Enantioselektive Reduktion von Ketonen.
NO883168L (no) Fremgangsmaate for aa bestemme fallet og retningen av en formajonsfraktur som skjaerer et borehull.
DE3869007D1 (de) Oxydation von alkanen.
NO881151D0 (no) Syntetisk hiv-1-antigen.
DE3785603D1 (de) Produktion von epsilon-kaprolaktam.
NO895026L (no) Retrovirale proteasehemmere.
DE68908950T2 (de) Anwendung von 15-Keto-prostaglandin-E- oder F-Verbindungen für uterine Kontraktionen.
DE3574674D1 (de) Mischung von 2-substituierten carbapenemen mit dipeptidase-inhibitoren.
DE3853055D1 (de) Oszillator mit YIG-Abstimmung.
ES2056086T3 (es) Procedimiento para la determinacion de fibrina soluble.
NO871883L (no) Fremgangsmaate for rensing av enkelt- og dobbeltkjedet vevplasminogenaktivator.
DE3582267D1 (de) Elektrochemische oxydation von pyridinbasen.
FI890459A (fi) Proteolytisk enzym specifik foer humant immunbristvirus och foerfarande foer dess syntetisering och renaturering.
DE68908625T2 (de) Modulation von gerichteten Strahlen.
DE3873721T2 (de) Oszillator mit geringem rauschen.
DE3865090D1 (de) Verpackungstechnik von batterien.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 306813

Country of ref document: ES